CASI - CASI Pharmaceuticals GAAP EPS of -$0.56 revenue of $8.57M beats by $0.7M
- CASI Pharmaceuticals press release ( NASDAQ: CASI ): Q2 GAAP EPS of -$0.56.
- Revenue of $8.57M (+19.7% Y/Y) beats by $0.7M .
- As of June 30, 2022, CASI had cash and cash equivalents of $18.9 million.
- Shares -6.41% PM.
For further details see:
CASI Pharmaceuticals GAAP EPS of -$0.56, revenue of $8.57M beats by $0.7M